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ABSTRACT 
Controlled stepwise reaction of a geminal substituted alkene or primary amine group afforded 
a small library of new functionalised tertiary and ditertiary phosphines. Accordingly, 
Mannich based condensation of the commercially available disubstituted arene C6H4(NH2){2-
C(Me)=CH2} with HOCH2PR2 (R2 = Cg: 1,3,5,7-tetramethyl-2,4,8-trioxa-6-
phosphaadamantyl; Ph2) afforded the (aminomethyl)phosphines C6H4(NHCH2PCg){2-
C(Me)=CH2} L1 and C6H4(NHCH2PPh2){2-C(Me)=CH2} L2 in approx. 60% yield. In 
addition to the formation of L2, the diphosphine L3 was also identified and independently 
synthesised upon reaction of C6H4(NH2){2-C(Me)=CH2} with two equiv. of HOCH2PPh2 in 
CH3OH under reflux. Alternatively, reaction of C6H4(NH2){2-C(Me)=CH2} with H-PR2 (R2 
= Cg or Ph2) in the presence of AIBN [2,2`-azobis(2-methylpropionitrile)] as free radical 
initiator, afforded the primary amine functionalised phosphines C6H4(NH2){2-
CH(Me)CH2PCg} L4 and C6H4(NH2){2-CH(Me)CH2PPh2} L5 in 85% and 66% isolated 
yields respectively. In both cases only the anti-Markovnikov addition products were 
observed. Subsequent reaction of L5 with HOCH2PR2 (R2 = Ph2) afforded the unsymmetrical 
ditertiary phosphine C6H4(NHCH2PPh2){2-CH(Me)CH2PPh2} L6. Some preliminary 
coordination studies towards [RuCl(µ-Cl)(η6-C10Η14)]2, [AuCl(tht)] (tht = 
tetrahydrothiophene) and [MCl2(η4-cod)] (M = Pd, Pt; cod = cycloocta-1,5-diene) 
demonstrate these new ligands behave as classic P-donors leaving the pendant amino or 
alkenyl groups non-coordinating. All compounds have been characterised by multinuclear 
NMR, FT−IR, mass spectrometry and microanalysis. Single crystal X-ray studies have been 
performed on L3, L5, L6, 1, 3b∙0.5CH2Cl2, 4a∙1.5CH2Cl2, 5 and 6∙0.5CDCl3∙0.5C4H10O 
 
Keywords: P ligands; Late-transition metals; X-ray crystallography; Organometallic 
complexes; Hydrophosphinations 
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1. Introduction 
The coordination and organometallic chemistry of late transition metal complexes using 
tertiary phosphines as ancillary ligands continues to attract much attention. In the quest for 
developing new P-based ligands, a plethora of synthetic methodologies have thus far been 
developed allowing precise control of factors such as the incorporation of suitable electronic 
groups, sterically bulky substituents, functional groups, chirality and solubility properties [1]. 
For a number of years, our research group has been interested in developing atom economical 
and facile procedures to phosphorus based ligands [2]. In particular we [3], and others [4], 
have successfully used Mannich based condensations for accessing new (aminomethyl) 
derivatised phosphines through C−N bond formation (Scheme 1, pathway a). Recently there 
has also been much interest in hydrophosphinations (Scheme 1, pathway b) as an entry route 
to P−C bond formation using suitable P−H precursors [5]. Single [6] or double [7] 
hydrophosphination of alkenes have been developed as well as metal catalysed double 
hydrophosphination of alkynes [8] leading to unsymmetric ditertiary phosphines. Webster et 
al [9] employed simple iron catalysts to promote catalytic intramolecular hydrophosphination 
of alkene or alkyne functionalised primary phosphines. Furthermore the scope of this 
approach has also been extended to the alternative use of phosphine oxides [R2P(O)−H or 
(RO)2P(O)−H] and applied in alkene [10a,10b], alkyne [10b], nitrile [11], or azobenzene [12] 
hydrophosphination reactions. Asymmetric palladium(II) catalysed hydrophosphinations 
have also achieved much recent prominence [13] for the preparation of chiral phosphine 
ligands. 
Herein we describe, using a commercially available starting material, the straightforward 
synthesis and characterisation of new amino- or alkenyl-functionalised tertiary monodentate 
and bidentate phosphines using Mannich based condensation and/or hydrophosphination 
protocols. We demonstrate the facile nature of the syntheses of these ligands opposed to 
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alternative P−C bond forming synthetic methods [14]. Furthermore we show these ligands 
function in a classical P-monodentate or µ-P,P-bridging manner through conducting some 
brief coordination studies to RuII, AuI, PdII, and PtII metal centres. All new compounds have 
been structurally verified by a combination of spectroscopic and crystallographic techniques. 
 
< Insert Scheme 1 and Scheme 1 caption here > 
 
 2. Experimental 
2.1. Materials 
All reactions were conducted under an inert atmosphere except for the coordination studies 
which were carried out in air using reagent grade quality solvents. The compounds [MCl2(η4-
cod)] (cod = cycloocta-1,5-diene) [15], [RuCl(µ-Cl)(η6-C10Η14)]2 [16], and [AuCl(tht)] (tht = 
tetrahydrothiophene) [17] were all prepared according to known procedures. HOCH2PR2 (R2 
= Cg or Ph2) [3a, 18] were prepared, either in situ or preformed, according to literature 
methods. 2-isopropenylaniline was obtained from Sigma-Aldrich and used directly without 
further purification. 
 
2.2. Instrumentation 
Infrared spectra were recorded as KBr pellets on either a Perkin-Elmer System 2000 
(4000−400 cm−1 range) or a Spectrum 100S (4000−250 cm−1 range) Fourier-Transform 
spectrometer. 1H NMR spectra (400 MHz) were recorded on a Bruker DPX-400 FT 
spectrometer with chemical shifts (δ) in ppm to high frequency of Si(CH3)4 and coupling 
constants (J) in Hz. 31P{1H} NMR spectra were recorded on a Bruker DPX-400 FT 
spectrometer with chemical shifts (δ) in ppm to high frequency of 85% H3PO4. NMR spectra 
were measured in CDCl3 at 298 K. Elemental analyses (Perkin-Elmer 2400 CHN or Exeter 
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Analytical, Inc. CE-440 Elemental Analyzers) were performed by the Loughborough 
University Analytical Service within the Department of Chemistry. Mass spectra were 
recorded within the Department of Chemistry at Loughborough University and by the EPSRC 
National Mass Spectrometry Service at Swansea University.  
 
2.3 Syntheses 
2.3.1 Preparation of C6H4(NHCH2PCg){2-C(Me)=CH2} (L1). A solution of CgPCH2OH 
(0.635 g, 2.57 mmol) in CH3OH (10 ml) was added to C6H4(NH2){2-C(Me)=CH2} ( (0.342 g, 
2.57 mmol) and the resulting solution stirred for 24 h at r.t. The solvent volume was reduced 
in vacuo to ~5 ml and the suspension kept in the freezer for 12 h. The resulting solid was 
collected by suction filtration and dried in vacuo. Yield: 0.600 g, 64%. 1H NMR [CDCl3]: δ 
7.21 (1H, virtual t, 3JHH 7.2, arom. H), 7.05 (1H, d, 3JHH 6.8, arom. H), 6.75 (2H, arom. H), 
5.33 (1H, s, =CH), 5.05 (1H, s, =CH), 4.74 (1H, bs, NH), 3.52 (1H, d, 2JHH 12.7, PCH2N), 
3.02 (1H, d, 2JHH 12.7, PCH2N), 2.17–1.21 (19H, m, CH2 + CH3, Cg). 31P{1H} NMR 
[CDCl3]: δ –33.3, –33.5. FT−IR (KBr): νNH 3428 cm–1. EI–MS (m/z) [MH]+ 362. Anal. (%) 
Calcd. for C20H28NO3P∙0.5H2O: C, 64.85; H, 7.89; N, 3.78. Found: C, 64.63; H, 7.32; N, 
3.86.  
 
2.3.2 Preparation of C6H4(NHCH2PPh2){2-C(Me)=CH2} (L2). A solution of 
C6H4(NH2){2-C(Me)=CH2} (0.300 g, 2.25 mmol) in CH3OH (7.5 ml) was added to a CH3OH 
solution (7.5 ml) of Ph2PCH2OH (0.487 g, 2.25 mmol) by cannula. The resulting mixture was 
stirred for 24 h and the solvent concentrated under reduced pressure to ~5 ml. The suspension 
was kept in the freezer for 12 h and the solid collected by suction filtration and dried in 
vacuo. Yield: 0.449 g, 60%. 1H NMR [CDCl3]: δ 7.54–7.32 (10H, m, arom. H), 7.20 (1H, dt, 
3JHH 7.3, 4JHH 1.5, arom. H), 6.99 (1H, dd, 3JHH 7.4, 4JHH 1.5, arom. H), 6.81 (1H, d, 3JHH 8.1, 
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arom. H), 6.72 (1H, vt, 3JHH 7.4 arom. H), 5.06 (1H, d, 2JHH 1.3, =CH), 4.74 (1H, d, 2JHH 1.3, 
=CH), 4.23 (1H, bs, NH), 3.83 (2H, d, 2JHP 4.5, PCH2N), 1.86 (3H, s, CH3). 31P{1H} NMR 
[CDCl3]: δ –18.5. FT−IR (KBr): νNH 3401 cm–1. EI–MS (m/z) [MH]+ 332. Anal. (%) Calcd. 
for C22H22NP∙0.5H2O: C, 78.65; H, 6.41; N, 4.16. Found: C, 79.09; H, 6.52; N, 4.21.  
 
2.3.3 Preparation of C6H4{N(CH2PPh2)2}{2-C(Me)=CH2} (L3). A solution of 
C6H4(NH2){2-C(Me)=CH2} (0.300 g, 2.25 mmol) and Ph2PCH2OH (0.974 g, 4.51 mmol) in 
CH3OH (10 ml) was refluxed for 12 d, cooled and the volume concentrated under reduced 
pressure resulting in a colourless solid. Yield: 0.695 g, 58%. 1H NMR [CDCl3]: δ 7.67–6.95 
(24H, m, arom. H), 5.00 (1H, s, =CH), 4.84 (1H, d, 2JHH 1.4, =CH), 4.41 (4H, s, PCH2N), 
1.81 (3H, s, CH3) ppm. 31P{1H} NMR [CDCl3]: δ –27.3. EI–MS (m/z) [MH]+ 530. Anal. (%) 
Calcd. for C35H34NP2: C, 79.26; H, 6.30; N, 2.72. Found: C, 79.38; H, 6.28; N, 2.64.  
 
2.3.4 Preparation of C6H4(NH2){2-CH(Me)CH2PCg} (L4). The compounds 
C6H4(NH2){2-C(Me)=CH2} (0.500 g, 3.75 mmol), CgPH (0.812 g, 3.75 mmol) and AIBN 
[2,2`-azobis(2-methylpropionitrile)] (0.085 g, 0.53 mmol) were placed in a Schlenk tube. The 
mixture was freeze–pump–thawed (3 times) and stirred at 110 oC for 24 h. The yellow oily 
product solidified upon cooling in the freezer. Yield: 1.112 g, 85%. 1H NMR [CDCl3]: δ 7.17 
(1H, dd, 3JHH 3.2, 4JHH 0.6, arom. H), 7.05 (1H, dd, 3JHH 3.2, 4JHH 0.6, arom. H), 6.83 (1H, vt, 
3JHH 3.2, arom. H), 6.71 (1H, d, 3JHH 3.2, arom. H), 3.61 (2H, bs, NH), 3.02 (1H, m, CH), 
2.27–1.12 (23H, m, CH2, CH3, Cg). 31P{1H} NMR [CDCl3]: δ –31.7, –31.9. FT−IR (KBr): 
νNH 3460, 3369 cm–1. EI–MS (m/z) [MH]+ 350. Anal. (%) Calcd. for C19H28NO3P: C, 65.96; 
H, 8.30; N, 4.04. Found: C, 65.31; H, 8.08; N, 4.01.  
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2.3.5 Preparation of C6H4(NH2){2-CH(Me)CH2PPh2} (L5). The compounds 
C6H4(NH2){2-C(Me)=CH2}  (0.500 g, 3.75 mmol), HPPh2 (0.698 g, 3.75 mmol) and AIBN 
(0.085 g, 0.53 mmol) were placed in a Schlenk tube. The mixture was freeze–pump–thawed 
(3 times) and stirred at 110 oC for 3 d. After that time more AIBN was added (0.024 g, 0.15 
mmol) and left for a further 2 d. The colourless oily product solidified upon addition of 
CH3OH (10 ml) and was purified by adding Et2O (5 ml). The resulting solid was collected by 
suction filtration and dried in vacuum. Yield: 0.789 g, 66%. 1H NMR [CDCl3]: δ 7.57–7.33 
(10H, arom. H), 7.25 (1H, dd, 3JHH 7.7, 4JHH 1.4, arom. CH), 7.06 (1H, dt, 3JHH 7.6, 4JHH 1.5, 
arom. H), 6.84 (1H, dt, 3JHH 7.5, 4JHH 1.2, arom. H), 6.65 (1H, dd, 3JHH 7.9, 4JHH 1.2, arom. 
H), 2.95 (2H, bs, NH), 2.75 (1H, m, CH), 2.49 (1H, dt, 2JHH 13.6, 3JHH 4.0, 2JHP 3.2, CH2), 
2.23 (1H, ddd, 2JHH 13.6, 3JHH 10.0, 2JHP 3.2, CH2), 1.49 (3H, d, 3JHH 6.8, CH3). 31P{1H} 
NMR [CDCl3]: δ –19.5. FT−IR (KBr): νNH 3462, 3377 cm–1. EI–MS (m/z) [MH]+ 320. Anal. 
(%) Calcd. for C21H22NP∙0.25CH3OH: C, 77.96; H, 7.08; N, 4.28. Found: C, 77.65; H, 6.64; 
N, 3.99.  
 
2.3.6 Preparation of C6H4(NHCH2PPh2){2-CH(Me)CH2PPh2} (L6). Method 1: L5 (0.100 
g, 0.313 mmol) and Ph2PCH2OH (0.081 g, 0.38 mmol) were placed in a Schlenk tube and 
degassed CH3OH (10 ml) added. The mixture was refluxed for 3 d and concentrated under 
reduced pressure to ~1 ml. The resulting solid was filtered off under vacuum. Yield: 0.074 g, 
46%. Method 2: L2 (0.200 g, 0.60 mmol), HPPh2 (0.224 g, 1.21 mmol) and AIBN (0.018 g, 
0.108 mmol) were placed in a Schlenk tube and degassed CH3OH (10 ml) added. The 
mixture was refluxed for 5 d, stirred for a further 2 d at r.t. and concentrated under reduced 
pressure to dryness. The resulting oil was solidified with Et2O (10 ml) and filtered off under 
vacuum. Yield: 0.052 g, 17% (not optimised). 1H NMR [CDCl3]: δ 7.60–7.27 (10H, m, arom. 
H), 7.25 (1H, dd, 3JHH 7.7, 4JHH 1.4, arom. H), 7.06 (1H, dt, 3JHH 7.7, 4JHH 1.4, arom. H), 6.84 
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(1H, dt, 3JHH 7.7, 4JHH 1.4, arom. H), 6.65 (1H, dd, 3JHH 7.7, 4JHH 1.4, arom. H), 3.30 (1H, bs, 
NH), 2.84–2.70 (1H, m, CH), 2.56–2.44 (1H, dt, 2JHH 12.3, 2JHP 4.0, 3JHH 4.0, CH2), 2.26 
(1H, ddd, 2JHH 12.3, 2JHP 4.0, 3JHH 8.0, CH2), 1.52 (3H, d, 3JHH 6.8, CH3). 31P{1H} NMR 
[CDCl3]: δ –19.6, –19.8. FT−IR (KBr): νNH 3400 cm–1. EI–MS (m/z) [MOH]+ 534, [MO2H]+ 
550. Anal. (%) Calcd. for C34H33NP2: C, 78.90; H, 6.43; N, 2.71. Found: C, 78.80; H, 6.45; 
N, 2.80. 
 
2.3.7 Preparation of 1. The solids L2 (0.084 g, 0.26 mmol) and [RuCl(µ-Cl)(η6-C10Η14)]2 
(0.092 g, 0.13 mmol) were dissolved in CH2Cl2 (10 ml) and the solution stirred for 1 h. The 
solvent was reduced in volume to ~1 ml and Et2O (20 ml) added to afford a red solid 1 which 
was collected by suction filtration and dried in vacuum. Yield: 0.132 g, 69%. 1H NMR 
[CDCl3]: δ 7.93–7.37 (10H, m, arom. H), 7.00–6.81 (1H, m, arom. H), 6.78 (1H, dd, 3JHH 7.8, 
4JHH 1.5, arom. H), 6.49 (1H, t, 3JHH 7.8, arom. H), 6.34 (1H, d, 3JHH 7.8, arom. H), 5.33 (2H, 
d, 3JHH 6.2, arom. CH), 5.20 (2H, d, 3JHH 6.2, arom. CH), 4.98 (1H, s, =CH), 4.56 (1H, s, 
=CH), 4.48 (2H, s, PCH2N), 4.18 (1H, bs, NH), 2.57 (1H, sept., 3JHH 7.0, CH), 1.94 (3H, s, 
CH3), 1.70 (3H, s, CH3), 0.87 (6H, d, 3JHH 7.0, CH3). 31P{1H} NMR [CDCl3]: δ 25.2. FT−IR 
(KBr): νNH 3390 cm–1. EI–MS (m/z) [M–Cl]+ 602. Anal. (%) Calcd. for 
C32H36NPRuCl2∙0.75CH2Cl2: C, 56.09; H, 5.39; N, 2.00. Found: C, 56.53; H, 5.38; N, 1.99.  
 
2.3.8 Preparation of 2a. To a CH2Cl2 (10 ml) solution of [AuCl(tht)] (0.115 g, 0.36 mmol) 
was added L2 (0.117 g, 0.35 mmol) as a solid in one portion. The colourless solution was 
stirred for 1 h, evaporated under vacuum to ~1−2 ml. Addition of Et2O (15 ml) afforded solid 
2a which was collected by suction filtration and dried under vacuum. Yield: 0.120 g, 59%. 1H 
NMR [CDCl3]: δ 7.71–7.46 (10H, m, arom. H), 7.15 (1H, dt, 3JHH 8.0, 4JHH 1.2, arom. H), 
6.99 (1H, dd, 3JHH 7.6, 4JHH 1.6, arom. H), 6.87 (1H, t, 3JHH 8.8, arom. H), 6.75 (1H, d, 3JHH 
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8.4, arom. H), 5.11 (1H, s, =CH), 4.75 (1H, s, =CH), 4.22 (2H, d, 2JPH 4.0, CH2), 1.87 (3H, s, 
CH3). 31P{1H} NMR [CDCl3]: δ 25.0. FT−IR (KBr): νNH 3381, νAuCl 327 cm–1. Anal. (%) 
Calcd. for C22H22NPAuCl: C, 46.86; H, 3.94; N, 2.48. Found: C, 46.34; H, 3.66; N, 2.52. 
Preparation of 2b. To a CH2Cl2 (10 ml) solution of [AuCl(tht)] (0.069 g, 0.22 mmol) was 
added L3 (0.057 g, 0.11 mmol) as a solid in one portion. The colourless solution was stirred 
for 30 min, evaporated under vacuum to ~1-2 ml. Addition of Et2O (25 ml) and n-hexanes 
(25 ml) afforded solid 2 which was collected by suction filtration and dried under vacuum. 
Yield: 0.056 g, 52%. 1H NMR [CDCl3]: δ 7.57–7.35 (20H, m, arom. H), 7.13 (1H, d, 3JHH 
7.2, arom. H), 7.05 (1H, dt, 3JHH 7.2, 4JHH 2.0, arom. H), 6.89 (1H, t, 3JHH 7.6, arom. H), 6.87 
(1H, dt, 3JHH 7.6, 4JHH 2.0 arom. H), 4.96 (4H, s, CH2), 4.94 (1H, s, =CH), 4.65 (1H, s, =CH), 
1.57 (3H, s, CH3). 31P{1H} NMR [CDCl3]: δ 16.1. FT−IR (KBr): νAuCl 332 cm–1. Anal. (%) 
Calcd. for C35H33NP2Au2Cl2: C, 42.27; H, 3.35; N, 1.41. Found: C, 42.27; H, 3.37; N, 1.45.  
 
2.3.9 Preparation of 3a. To a CH2Cl2 (10 ml) solution of [PdCl2(η4-cod)] (0.043 g, 0.15 
mmol) was added L2 (0.100 g, 0.30 mmol) as a solid in one portion. The orange solution was 
stirred for 1 h, evaporated under vacuum to ~1-2 ml and addition of Et2O (20 ml) afforded 3a 
which was collected by suction filtration and dried under vacuum. Yield: 0.087 g, 69%. 1H 
NMR [CDCl3]: δ 7.85–6.94 (m, arom. H), 6.78 (2H, dt, CH), 6.58 (1H, d, 3JHH 8.4, arom. H), 
6.41 (1H, d, 3JHH 8.4, arom. H), 5.13 (1H, dd, =CH), 5.01 (1H, dd, =CH), 4.78 (2H, multiplet, 
=CH), 4.68 (1H, bs, NH), 4.43 (4H, s, PCH2N), 4.38 (4H, s, PCH2N), 1.92 (6H, s, CH3), 1.86 
(6H, s, CH3). 31P{1H} NMR [CDCl3]: δ 26.8, 14.3 (ca. 45:55 ratio of cis/trans isomers). 
FT−IR (KBr): νNH 3402, νNH 307, 283 cm–1. EI–MS (m/z) [M–Cl]+ 803. Anal. (%) Calcd. for 
C44H44N2P2PdCl2∙0.25CH2Cl2: C, 61.69; H, 5.22; N, 3.25. Found: C, 61.24; H, 5.20; N, 3.26. 
In a similar manner the platinum(II) complex 3b was synthesised (75%). 1H NMR [CDCl3]: δ 
7.88–7.42 (20H, m, arom. H), 7.08 (3H, m, arom. H), 6.64 (1H, d, 3JHH 6.8 arom. H), 5.09 
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(1H, s, =CH), 4.76 (1H, s, =CH), 4.23 (4H, vt, 3JPtH 40, 2JPH 1.6, CH2), 1.92 (3H, s, CH3). 
31P{1H} NMR [CDCl3]: δ 7.3 (1JPPt 3661). FT−IR (KBr): νPtCl 316, 290 cm–1. Anal. (%) 
Calcd. for C44H44N2P2PtCl2: C, 56.89; H, 4.78; N, 3.02. Found: C, 57.65; H, 4.94; N, 2.82. 
 
2.3.10 Preparation of 4a. To a CH2Cl2 (10 ml) solution of [PdCl2(η4-cod)] (0.041 g, 0.14 
mmol) was added L3 (0.077 g, 0.15 mmol) as a solid in one portion. The yellow solution was 
stirred for 1 h, evaporated under vacuum to ~1-2 ml whereupon a yellow solid started to 
deposit. Addition of Et2O (20 ml) afforded solid 4a which was collected by suction filtration 
and dried under vacuum. Yield: 0.094 g, 92%. 1H NMR [CDCl3]: δ 7.81–7.42 (20H, m, arom. 
H), 7.03 (3H, m, arom. H), 6.59 (1H, d, 3JHH 7.8, arom. H), 4.72 (1H, s, =CH), 4.62 (1H, s, 
=CH), 3.92 (4H, s, CH2), 1.57 (3H, s, CH3). 31P{1H} NMR [CDCl3]: δ 10.0. FT−IR (KBr): 
νPtCl 307, 294 cm–1. Anal. (%) Calcd. for C35H33NP2PdCl2: C, 59.46; H, 4.71; N, 1.98. Found: 
C, 58.97; H, 4.59; N, 2.06. In a similar manner the platinum(II) complex 4b was synthesised 
(94%). 1H NMR [CDCl3]: δ 7.88–7.42 (20H, m, arom. H), 7.08 (3H, m, arom. H), 6.64 (1H, 
d, 3JHH 6.8 arom. H), 4.74 (1H, s, =CH), 4.67 (1H, s, =CH), 4.03 (4H, vt, 3JPtH 40.0, 2JPH 1.6, 
CH2), 1.46 (3H, s, CH3). 31P{1H} NMR [CDCl3]: δ −6.1 (1JPPt 3417). FT−IR (KBr): νPtCl 313, 
289 cm–1. Anal. (%) Calcd. for C35H33NP2PtCl2∙0.5Et2O: C, 53.37; H, 4.61; N, 1.68. Found: 
C, 53.85; H, 4.64; N, 1.60. 
 
2.3.11 Preparation of 5. From L6 (0.050 g, 0.096 mmol) and [PtCl2(η4-cod)] (0.036 g, 0.096 
mmol) in CH2Cl2 and precipitation with Et2O. Yield: 0.060 g, 80%. 1H NMR [CDCl3]: δ 
7.92–6.95 (20H, m, arom. H), 6.47 (2H, t, 3JHH 6.0, arom. H), 6.34 (1H, dd, 3JHH 8.0, 4JHH 
1.2, arom. H), 6.18 (1H, d, 3JHH 9.2, arom. H), 5.32–5.27 (1H, m, PCH2N), 4.30 (1H, m, NH), 
3.57–3.47 (1H, m, CH), 3.42 (1H, bt,  3JHH 12.8, PCH2N), 2.67 (1H, q, 3JHH 13.6, CH), 1.97 
(1H, q, 3JHH 8.4, CH), 1.78 (3H, dd, 3JHH 16.0, J 2.0, CH3). 31P{1H} NMR [CDCl3]: δ 26.9 
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(1JPPt 3768, 2JPP 9), 11.3 (1JPPt 3479, 2JPP 9). FT−IR (KBr): νNH 3358, νPtCl 316, 291 cm–1. EI–
MS (m/z) [M–Cl]+ 747. Anal. (%) Calcd. for C34H33NP2PtCl2: C, 52.12; H, 4.24; N, 1.79. 
Found: C, 51.74; H, 4.13; N, 1.76.  
 
2.3.12 Preparation of 6. From L6 (0.0052 g, 0.010 mmol) and [RuCl(µ-Cl)(η6-C10Η14)]2 
(0.0060 g, 0.0098 mmol) in CDCl3 (0.5 ml). After NMR data acquisition, vapour diffusion 
with Et2O afforded red crystals. Yield: 0.0079 g, 73%. 1H NMR [CDCl3]: δ 7.78 (2H, t, arom. 
H), 7.70 (2H, t, arom. H), 7.61 (2H, t, arom. H), 7.48 (2H, t, arom. H), 7.40 (5H, s, arom. H), 
7.29-7.20 (5H, m, arom. H), 7.11 (2H, t, arom. H), 6.62 (1H, d, 3JHH 8.4, arom. H), 6.45 (1H, 
t, 3JHH 7.2, arom. H), 6.20 (1H, d, 3JHH 7.6, arom. H), 5.86 (1H, d, 3JHH 8.0, arom. H), 5.40–
4.99 (8H, m, CHcymene), 4.18 (2H, s, PCH2N), 2.88 (2H, m, PCH2), 2.51 [3H, m, CH and 
CH(CH3)2], 1.88 (3H, s, C6H4CH3), 1.79 (3H, s, C6H4CH3), 0.96–0.50 (15H, m, CH3 and 
CH(CH3)2]. 31P{1H} NMR [CDCl3]: δ 25.1, 21.6. Anal. (%) Calcd. for 
C54H61NP2Ru2Cl4∙0.25CDCl3: C, 56.17; H, 5.33; N, 1.21. Found: C, 55.77; H, 5.11; N, 1.33. 
 
2.4. X-ray crystallography 
Suitable crystals of L3 were obtained from an in situ NMR aliquot of the reaction between 1 
equiv. C6H4(NH2){2-C(Me)=CH2}  and two equiv. of Ph2PCH2OH in MeOH. Compounds L5 
and L6 were crystallised upon allowing a CH3OH filtrate to stand for several days. Red block 
crystals of the ruthenium(II) complex 1 were obtained by vapour diffusion of Et2O into a 
CHCl3 solution. The complexes 3b∙0.5CH2Cl2, 4a∙1.5CH2Cl2 and 5 were obtained by vapour 
diffusion of Et2O into a CH2Cl2 solution whereas complex 6∙0.5CDCl3∙0.5C4H10O was 
obtained by vapour diffusion of Et2O into a CDCl3 solution. Details of the data collection 
parameters and crystal data for L3, L5, L6, 1, 3b∙0.5CH2Cl2, 4a∙1.5CH2Cl2, 5 and 
6∙0.5CDCl3∙0.5C4H10O are given in Table 1. Measurements for L3, L5, L6, 1, 3b∙0.5CH2Cl2, 
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4a∙1.5CH2Cl2, 5 and 6∙0.5CDCl3∙0.5C4H10O were made on modern CCD diffractometers 
using graphite-monochromated radiation from a rotating anode source (for 5) or sealed tube 
source (all others) [19]. Intensities were corrected semi-empirically for absorption, based on 
symmetry-equivalent and repeated reflections [19, 20]. The structures were solved [21] by 
direct or dual-space methods and refined on F2 values for all unique data by full-matrix least 
squares [21, 22]. All non-hydrogen atoms were refined anisotropically. Carbon-bound 
hydrogen atoms were constrained in a riding model with Ueq set to 1.2Ueq of the carrier atom 
(1.5 Ueq for methyl hydrogen). NH coordinates were freely refined, except for those in 
3b∙0.5CH2Cl2 which were constrained with Ueq set to 1.2Ueq of the carrier atom. For 1 C–
CH3 and =CH2 atoms were modelled as 50/50 disordered on atoms C(31) and C(32). For 
3b∙0.5CH2Cl2 one molecule of CH2Cl2 was modelled as 2-fold disordered with a major 
component 63.6(16)%. The H atoms on the terminal =CH2 and C–CH3 groups at C(9)/C(10) 
and C(9A)/C(10A) were also modelled as two-fold disordered with major components 
58(11)% and 54(11)% respectively. In these two cases, as in 1 above, the C−C bond lengths 
were very similar and the sites could also not be distinguished based on H atom electron 
density. For 4a∙1.5CH2Cl2 one of the CH2Cl2 molecules of crystallisation was modelled as 
two-fold disordered with major component occupancy 57.6(10)%. For 
6∙0.5CDCl3∙0.5C4H10O the solvent of crystallisation was modelled using the Platon Squeeze 
procedure [23]. This recovered 85 electrons in one void which corresponds roughly to one 
CDCl3 and one Et2O per unit cell, which agreed with point atom observations. 
 
2. Results and Discussion 
3.1. Ligand Synthesis 
The amino(methyl)phosphines L1 and L2 were synthesised in ~60% yield upon reaction of 
one equiv. of HOCH2PR2 [readily prepared from equimolar amounts of (CH2O)n and Ph2PH 
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[18] or CgPH [3d] respectively] and one equivalent of C6H4(NH2){2-C(Me)=CH2} in CH3OH 
(Scheme 1). There has been much interest in the Cg group, as seen here in L1, for its steric 
properties [3a], diverse coordination behaviour [2, 3a, 6g] and versatility in homogeneous 
metal catalysed reactions [24a]. For L2, small amounts of the disubstituted phosphine L3 were 
also formed during the reaction as observed by in situ NMR spectroscopy [δ(P) −27.0]. To 
confirm this assignment, reaction of two equiv. of Ph2PCH2OH with one equiv. of 
C6H4(NH2){2-C(Me)=CH2} in refluxing CH3OH afforded L3 in 58% yield. Other 
characterising data for L1−L3 are given in the Experimental Section and are broadly as 
expected. In the 1H NMR spectra of L1 and L2 the PCH2N methylene protons showed an 
ABX splitting pattern (A and B for the diastereotopic protons and X for the P).  
 
< Insert Scheme 2 and Scheme 2 caption here > 
 
The X-ray structure of L3 has been determined (Fig. 1) and supports the spectroscopic and 
analytical characterising data. Both phosphorus atoms are pyramidal as reflected by the 
C−P−C bond angles whilst P−C and C−N bond lengths and P−C−N/C−N−C bond angles are 
in agreement with previously reported ligands of this type [3]. The C(7)−C(8) bond length of 
1.329(3) Å is consistent with a C=C double bond and is shorter than that found in L5 and L6 
(vide infra). 
 
< Insert Table 1 and Table 1 caption here > 
<Insert Figure 1 and Figure 1 caption here > 
 
The primary amine functionalised tertiary phosphines L4 and L5 were prepared by free 
radical catalysed hydrophosphination using equimolar amounts of C6H4(NH2){2-
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C(Me)=CH2} and secondary phosphines (H-PR2, R2 = Cg or Ph2) with AIBN at 110 ºC for 5 
d. Cui and co-workers recently showed that a NHC-Yb(III) amide complex 
hydrophosphinates Ph2C=CH2, when reacted with Ph2PH, at r.t. for 4 h with 100% 
conversion [6c]. No efforts toward double hydrophosphination of C6H4(NH2){2-
C(Me)=CH2} with primary phosphines have been attempted. Compound L5 was obtained as a 
yellowish oil which solidified upon adding CH3OH and the resulting colourless solid was 
purified with Et2O (see Experimental Section). The 31P{1H} NMR spectrum of L5 showed a 
singlet at δ(P) −19.5, similar to that found for L2. The linear isomer of L5 was formed in 
excellent regioselectivity with no observable NMR evidence for the branched isomer. Hence 
three well defined sets of resonances in the region between δ(H) 2.75−2.23 for L5, 
corresponding to the methine and diastereotopic methylene protons, support the terminal 
addition of the “H”/“PPh2” groups across the C(Me)=CH2 bond. Suitable crystals of L5 were 
obtained from a CH3OH filtrate with the molecular structure shown in Fig. 2. The C−C and 
C−C−C parameters for C(8)−C(7), C(7)−C(6) and C(7)−C(9) are in agreement with typical 
single C−C bond lengths and C−C−C angles. 
 
< Insert Figure 2 and Figure 2 caption here > 
 
To demonstrate the free –NH2 group is susceptible to further reaction, initial NMR 
monitoring of the reaction between L5 with Ph2PCH2OH, in a 1:1 stoichiometry, showed no 
reaction. Nevertheless, after several hours, a solid precipitated which, after NMR inspection, 
revealed two closely spaced peaks around δ(P) −19 [25] assigned to the unsymmetrical 
diphosphine L6. The yield could be increased after some optimisation work. No one-pot 
approach to the preparation of L6 has been attempted in this study. This procedure therefore 
has potential scope for expanding this class of ligand through simple manipulation of the 
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appropriate secondary phosphine or hydroxymethylditertiary phosphine. Crystals of L6 were 
obtained from a CH3OH filtrate. The P−C/C−C bond lengths and the P−C−C/C−C−C bond 
angles are fairly similar to those found in L5 whereas the C−N and P−C−N values are in 
accordance with literature values [3]. The C(7)−C(8) and C(7)−C(9) bond lengths are 
consistent with single C−C bonds. 
 
< Insert Figure 3 and Figure 3 caption here > 
 
3.2. Metal coordination studies 
The ligating ability of L2 and L3 was assessed through a range of simple coordination studies 
towards [RuCl(µ-Cl)(η6-C10Η14)]2, [AuCl(tht)] and [MCl2(η4-cod)] (M = Pd, Pt) in the 
appropriate stoichiometry, in CH2Cl2 and at r.t., affording the complexes 1−4b in 52−94% 
isolated yields. The characterising details for these compounds is as expected and 
furthermore, in the case of the dichloropalladium(II) complex 3a both cis (3a) and trans (3aa) 
isomers were observed whereas for the dichloroplatinum(II) complex 3b only the cis isomer 
was observed in solution. 
 
< Insert Table 2 and Table 2 caption here > 
< Insert Chart 1 and Chart 1 caption here > 
 
The molecular structures of the ruthenium(II) complex 1 (Fig. 4), 3b∙0.5CH2Cl2 (Fig. 5) and 
the dichloropalladium(II) complex 4a∙1.5CH2Cl2 (Fig. 6) have each been determined by 
single crystal X-ray crystallography (Table 2 and Figure Captions for selected geometrical 
parameters). The structures are broadly as anticipated reflecting their piano-stool (for 1) or 
square-planar arrangements (for 3b∙0.5CH2Cl2 and 4a∙1.5CH2Cl2) around the metal centre. 
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Moreover, in all three structures the alkenyl C=C bond length is in the region 
1.311(15)−1.361(15) Å consistent with the absence of any binding to the metal centre in any 
of these examples. We note that the –CH3 and =CH2 groups are often disordered in the solid 
state, since they occupy similar volumes within the unit cell. 
 
< Insert Figure 4 and Figure 4 caption here > 
 
< Insert Figure 5 and Figure 5 caption here > 
 
< Insert Figure 6 and Figure 6 caption here > 
 
The coordination capability of the asymmetric aminomethylphosphine L6 was also 
investigated towards [PtCl2(η4-cod)] and [RuCl(µ-Cl)(η6-C10Η14)]2. The synthesis of the cis 
isomer 5 (isolated in 80% yield) was achieved by reacting [PtCl2(η4-cod)] and one equiv. of 
L6. In the 31P{1H} NMR spectrum, two resonances at δ(P) 26.9 and 11.3 were observed with 
associated JPtP coupling constants of 3768 and 3479 respectively. Known reported 
compounds with medium sized chelate rings showed two phosphorus signals flanked by 195Pt 
satellites with values similar to 5 [25, 26]. The FT−IR spectrum shows two νPtCl vibrations 
(316 and 291 cm−1) consistent with cis-chelation and an νNH vibration at 3358 cm−1. Bridge 
cleavage of the dimer [RuCl(µ-Cl)(η6-C10Η14)]2 with 1 equiv. of  L6 in CDCl3 gave the new 
bimetallic complex 6 as confirmed by 1H and 31P{1H} NMR spectroscopy. The phosphorus 
chemical shifts for the two inequivalent 31P centres (δ 25.1 and 21.6) are very similar to that 
found in 1 and furthermore show a downfield shift with respect to the free ligand L6. The 1H 
NMR spectrum of 6 showed the anticipated resonances for the two inequivalent p-cymene 
ligands. The bridging behaviour observed here for L6 contrasts with that previously observed 
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for C6H4(NHCH2PPh2)(2-PPh2) [25] in which both P-monodentate and P,P-chelating modes 
towards late transition metal centres were observed. 
 
The structures of the dichloroplatinum(II) complex 5 (Fig. 7) and the dinuclear ruthenium(II) 
complex 6∙0.5CDCl3∙0.5C4H10O (Fig. 8) were confirmed by single crystal X-ray 
crystallography (Table 2). The square planar environment around the Pt(II) centre is clearly 
evident from the relevant bond angles and 5 displays typical Pt−P and Pt−Cl bond lengths. 
The phosphine forms a nine-membered metallacycle at the platinum(II) centre. The X-ray 
structure of 6∙0.5CDCl3∙0.5C4H10O confirms a bimetallic arrangement of [RuCl2(η6-C10Η14)] 
metal fragments supported by a bridging L6 diphosphine ligand. The Ru−P and Ru−Cl bond 
lengths in 6∙0.5CDCl3∙0.5C4H10O are similar to previously reported examples [27] and both 
ruthenium(II) metal centres show piano-stool arrangements. 
 
< Insert Figure 7 and Figure 7 caption here > 
 
< Insert Figure 8 and Figure 8 caption here > 
 
4. Conclusions 
In summary, we have shown that new functionalised (aminomethyl)phosphines are readily 
obtainable through simple Mannich based condensation or hydrophosphination reactions of a 
1,2-disubstituted arene. The resulting phosphine ligands display classic ligating behaviour at 
various late transition metal centres. Given the diversity of known R substituents this 
approach should be amenable to other ligand systems by careful choice of R2PCH2OH and 
R2PH precursors. 
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